tradingkey.logo

BUZZ-Palatin Technologies down after launching stock sale

ReutersFeb 12, 2025 2:41 PM

Shares of Delaware-based drug developer Palatin Technologies PTN.A down 11% to 89 cents

Co, which develops treatments of diseases such as autoimmune and dry eye diseases, launches stock offering

PTNA to sell up to $6 million common shares through Alliance Global Partners acting as its sales agent

Co has ~26.01 mln shares outstanding for a roughly $26 mln market value and ~18.9 mln shares of public float - LSEG

Avg rating among 2 analysts is "buy" with $17 median PT - LSEG

In the last 12 months, stock has fallen 50.7%

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI